Evidence map›Paper›PMID 40596569›Full record

SynthesisScientific reports2025

Prognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis.

Jingxian Yang, Yongjie Chen, Jun Wan, Feina Li, Xinyu Yang, Binger Shen, Na Li, Jiajia Didi, Lijiao Zhou, Yu Zhang

Abstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jingxian YangCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yongjie Chen *Department of critical care medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Jun Wan *Center for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Feina LiDepartment of critical care medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Xinyu YangCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Binger ShenDepartment of critical care medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Na LiCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Jiajia DidiDepartment of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Lijiao ZhouDepartment of critical care medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yu ZhangCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China. zhangyu1057@cdu.edu.cn.

Funding

National Natural Science Foundation of China 82271364
6 · The paper itself

Abstract

Stroke poses a significant mortality threat and frequently results in survivors experiencing varying degrees of residual disability. The objective of this meta-analysis was to elucidate the association between C-reactive protein-to-albumin ratio (CAR) and prognosis in patients with stroke. We searched the databases of PubMed, Embase, the Cochrane Library, and CNKI for relevant studies up to 26th January 2024. The quality of the included studies was evaluated using the Newcastle Ottawa Quality Assessment Scale (NOS). Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated for the association between CAR and poor functional outcomes and mortality. A total of nine studies with 2954 patients were included. The pooled results demonstrated that elevated CAR was associated with poor functional outcomes in patients with stroke (OR: 2.24; 95% CI: 1.81-2.78; P < 0.00001). Similarly, elevated CAR was associated with mortality in patients with stroke (OR: 2.11; 95% CI: 1.51-2.94; P < 0.0001). CAR has prognostic value for poor functional outcomes and mortality in patients with stroke.

Indexed as

C-Reactive ProteinSerum AlbuminStrokeBiomarkersHumansPrognosisBiomarkersC-Reactive ProteinSerum AlbuminAlbuminC-reactive proteinMeta-analysisMortalityStroke

Identifiers

PMID40596569
PMCPMC12218144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.